tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Phase 3 Trial Results and Growth Potential for Bioxcel Therapeutics’ BXCL501 Reinforce Buy Rating
PremiumRatingsPromising Phase 3 Trial Results and Growth Potential for Bioxcel Therapeutics’ BXCL501 Reinforce Buy Rating
15d ago
BioXcel Therapeutics price target raised to $4 from $2 at Mizuho
Premium
The Fly
BioXcel Therapeutics price target raised to $4 from $2 at Mizuho
18d ago
Sell Rating on Bioxcel Therapeutics Amid Efficacy and Strategic Concerns
Premium
Ratings
Sell Rating on Bioxcel Therapeutics Amid Efficacy and Strategic Concerns
19d ago
BioXcel Therapeutics completes database lock for SERENITY Phase 3 trial
PremiumThe FlyBioXcel Therapeutics completes database lock for SERENITY Phase 3 trial
1M ago
BioXcel Therapeutics’ BXCL501 Gains Momentum with FDA Support and Positive Phase 3 Trial Outcomes, Analyst Recommends Buy with $10 Price Target
Premium
Ratings
BioXcel Therapeutics’ BXCL501 Gains Momentum with FDA Support and Positive Phase 3 Trial Outcomes, Analyst Recommends Buy with $10 Price Target
1M ago
Bioxcel Therapeutics Files Prospectus for $80M Share Sale
Premium
Company Announcements
Bioxcel Therapeutics Files Prospectus for $80M Share Sale
1M ago
BioXcel Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsBioXcel Therapeutics Reports Q2 2025 Financial Results
2M ago
BioXcel Therapeutics trading resumes
Premium
The Fly
BioXcel Therapeutics trading resumes
2M ago
BioXcel Therapeutics trading halted, volatility trading pause
Premium
The Fly
BioXcel Therapeutics trading halted, volatility trading pause
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100